OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells presents a paramount challenge to the biopharmaceutical industry. Multiple strategies are employed to antibody titer, including process parameter optimization, genetic engineering, and adoption of perfusion technologies. Fine-tuning growth parameters plays a